Merve Demirbag Karaali

Merve Demirbag Karaali

Auto-generated profile, based on publicly available information

Merve Demirbag Karaali

Department of Biology, Institute of Science, Bursa Uludag University, Nilufer, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Cumhuriyet Science Journal
Verified
Journal Article
Closed access
PDF file
MSMehmet Sarimahmut
Mehmet Sarimahmut
SVSindi Vekshari̇
Sindi Vekshari̇
MKMerve Demi̇rBag Karaali̇
Merve Demi̇rBag Karaali̇
SCSerap Celikler
Serap Celikler
Phytochemicals have a vast number of properties contributing to human health by acting on numerous different mechanisms. Phloridzin, a phytochemical mainly found in Malus species, possesses diverse biological activities including anti-diabetic and antioxidative activities. Here, our aim is to explore antigenotoxic potential and proliferative effects of phloridzin on human lymphocytes in vitro by employing chromosome aberration, micronucleus and comet assays. Mitomycin C, both an anticancer and genotoxic agent, was utilized to induce genotoxicity. Phloridzin significantly suppressed the genotoxic effects of mitomycin C at 125-500 µg/mL concentrations in all assays used (p < 0.05). We also revealed that phloridzin and mitomycin C combination had a significantly negative effect on mitotic index (p < 0.05), whereas in general, gender differences did not play a role in manifestation of neither antigenotoxic nor antiproliferative activities of the combination.These results suggest that phloridzin is an antigenotoxic compound and its consumption may interfere with the activity of anticancer drugs that exert their effects based on genotoxic mechanisms.

11 September 2026 in Pediatric Allergy, Immunology, and Pulmonology
Verified
Journal Article
Closed access
MKMerve Demirbag Karaali
Merve Demirbag Karaali
SRSimpel Pantir Retzep
Simpel Pantir Retzep
ZKZuhal Karali
Zuhal Karali
YKYasin Karali
Yasin Karali
EYElif UZ YILDIRIM
Elif UZ YILDIRIM
SCSukru Cekic
Sukru Cekic
Introduction:: Hereditary angioedema (HAE) is a rare, potentially life-threatening genetic condition characterized by recurrent episodes of localized tissue swelling, often affecting the skin, upper respiratory tract, and gastrointestinal system. HAE-FXII, also known as HAE with normal C1 inhibitor ( C1INH ), has been associated with mutations in only one of several genes, including FXII encoding coagulation factor XII (FXII). The aim of the study was to investigate the pathogenicity and functional consequences of the c.1681-7G>A intronic variant in the FXII gene according to ACMG guidelines in familial cases of HAE-FXII. Materials and Methods:: Genetic analysis was performed using Sanger sequencing on affected individuals. To assess whether the variant affects splicing, in silico analysis and Messenger RNA (mRNA) studies were conducted on patient-derived samples. Results:: The c.1681-7G>A variant was identified in multiple individuals from affected families. However, splicing analysis revealed that this intronic variant did not cause any alteration in mRNA processing. No aberrant transcripts were detected, and expression levels were comparable to controls, indicating that the variant does not have an effect on splicing or gene function. Discussion:: The c.1681-7G>A variant in the FXII gene is unlikely to be a pathogenic alteration in HAE type III. Contribution to the Literature:: These findings support its classification as a benign variant, emphasizing the importance of functional validation when interpreting intronic changes in genetic diagnostics.